ReviewMolecular and clinical oncology2026
Hearing impairment following radiotherapy in patients with nasopharyngeal carcinoma (Review).
Review in Molecular and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nasopharyngeal carcinoma (NPC) is a geographically prevalent malignant mucosal tumor endemic to southern China and Southeast Asia. Radiotherapy constitutes the core curative treatment for NPC, often combined with chemotherapy or targeted therapy in clinical practice. Hearing loss is a common radiotherapy-related complication caused by radiation damage to middle ear structures, inner ear cells and auditory nerves, with a variable incidence affected by treatment protocols and patient characteristics. Such auditory dysfunction negatively impacts patients' cognition, emotion and quality of life. However, systematic summaries of subjective evaluation tools and targeted non-surgical rehabilitation strategies for radiotherapy-induced hearing impairment remain insufficient. Accordingly, this review aims to elaborate on the classification, multidimensional clinical impacts, subjective assessment scales, and non-surgical interventions of radiotherapy-related hearing loss, so as to provide evidence-based references for clinical rehabilitation of NPC survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.